Literature DB >> 7004350

Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics.

E J Goldstein, M E Gombert, E O Agyare.   

Abstract

In vitro susceptibility testing of 28 strains of Eikenella corrodens by the agar dilution technique showed that all strains were uniformly susceptible to penicillin, ticarcillin, cefoxitin, cefotaxime, N-formimidoyl thienamycin, and moxalactam and resistant to clindamycin and cefadroxil. Cefoperazone, piperacillin, and mezlocillin showed good activity, with some strains relatively resistant. Bacampicillin and cefamandole showed relatively poor activity.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7004350      PMCID： PMC284099          DOI： 10.1128/AAC.18.5.832

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Susceptibility of Eikenella corrodens to ten cephalosporins.

Authors:  E J Goldstein; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

Review 2.  Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse.

Authors:  G F Brooks; J M O'Donoghue; J P Rissing; K Soapes; J W Smith
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

3.  Isolation of bacillus HB-1 from human clinical sources.

Authors:  E J Bottone; J Kittick; S S Schneierson
Journal:  Am J Clin Pathol       Date:  1973-04       Impact factor: 2.493

4.  Eikenella corrodens endocarditis: report of cure in two cases.

Authors:  J E Geraci; P E Hermans; J A Washington
Journal:  Mayo Clin Proc       Date:  1974-12       Impact factor: 7.616

5.  Infections with Eikenella corrodens. A newly recognized human pathogen.

Authors:  G J Dorff; L J Jackson; M W Rytel
Journal:  Ann Intern Med       Date:  1974-03       Impact factor: 25.391

6.  Bacteriology of human and animal bite wounds.

Authors:  E J Goldstein; D M Citron; B Wield; U Blachman; V L Sutter; T A Miller; S M Finegold
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

7.  Eikenella corrodens: a new pathogen.

Authors:  F J DeMello; M S Leonard
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1979-05

8.  Recurrent meningitis and brain abscess caused by Eikenella corrodens.

Authors:  A M Emmerson; F Mills
Journal:  Postgrad Med J       Date:  1978-05       Impact factor: 2.401

9.  Sinus infection due to Eikenella corrodens.

Authors:  J P Dudley; E J Goldstein; W L George; B V Bock; B D Kirby; S M Finegold
Journal:  Arch Otolaryngol       Date:  1978-08

10.  Isolation of Eikenella corrodens in a general hospital.

Authors:  S H Zinner; A K Daly; W M McCormack
Journal:  Appl Microbiol       Date:  1973-05
View more
  10 in total

1.  In vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates.

Authors:  Emilia Cercenado; Sonia Cercenado; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Infective endocarditis due to Eikenella corrodens: Case report and review of the literature.

Authors:  W D Patrick; W D Brown; M Ian Bowmer; C P Sinave
Journal:  Can J Infect Dis       Date:  1990

3.  Characterization of a beta-lactamase-specifying plasmid isolated from Eikenella corrodens and its relationship to a commensal Neisseria plasmid.

Authors:  R Rotger; E García-Valdés; E P Trallero
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 4.  Lung abscess due to Eikenella corrodens: three cases and review.

Authors:  A Kentos; P De Vuyst; M J Stuelens; F Jacobs; P de Francquen; B Delaere; P Demaeyer; J P Thys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

5.  In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 6.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

7.  Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens.

Authors:  E J Goldstein; C E Cherubin; M Shulman
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

8.  Prevalence of Eikenella corrodens in dental plaque.

Authors:  E J Goldstein; L A Tarenzi; E O Agyare; J R Berger
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

9.  Comparison of broth microdilution method using Haemophilus test medium and agar dilution method for susceptibility testing of Eikenella corrodens.

Authors:  L Alcalá; F García-Garrote; E Cercenado; T Peláez; G Ramos; E Bouza
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

10.  Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.